Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668851 | SCV000793523 | likely pathogenic | Multiple epiphyseal dysplasia type 4 | 2017-08-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001861770 | SCV002231315 | pathogenic | Achondrogenesis, type IB; Atelosteogenesis type II; Multiple epiphyseal dysplasia type 4; Diastrophic dysplasia | 2021-10-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 553407). This variant has not been reported in the literature in individuals affected with SLC26A2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser193*) in the SLC26A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC26A2 are known to be pathogenic (PMID: 7923357, 10482955, 11241838). |
Baylor Genetics | RCV003472107 | SCV004201791 | likely pathogenic | Achondrogenesis, type IB | 2022-12-18 | criteria provided, single submitter | clinical testing |